Monographie - Alprostadil

Poslední aktualizace :
27/11/2024

Alprostadil

Chemický vzorec

Obchodní název

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Alfaprostin	Egypt
Alistint	Peru
Alpros	Turecko
Alprostadil	äpanÏlsko, Argentina, Chile, Ekvádor, Kanada, Malajsie, NÏmecko, Peru, Rumunsko, Turecko, USA
Alprostapint	Argentina, Ekvádor, Kolumbie, MaÔarsko, Peru, Rakousko
Alprostar	Itálie
Aplicav	BrazÌlie
Cardiobon	Argentina, Peru
Caverject	äpanÏlsko, Belgie, BrazÌlie, Dánsko, Francie, Itálie, Jihoafrická republika, Kanada, Norsko, Polsko, Portugalsko, Rakousko, Slovinsko, Švédsko, Švýcarsko, Turecko, USA, Velká Británie
Edex	Francie
Liple	Japonsko
Minprog	NÏmecko, Rakousko
Ostapint	Mexiko, Peru
Palux	Japonsko
Pridax	äpanÏlsko, NÏmecko, Rakousko, Rumunsko
Prolisina VR	Argentina
Prostandin	Japonsko
Prostavasin	Egypt, Írán, Itálie, Lucembursko, MaÔarsko, NÏmecko, Polsko, Rakousko
Prostin VR	Austrálie, Belgie, Dánsko, Finsko, Írán, Itálie, Kanada, Lucembursko, Malajsie, MaÔarsko, Nizozemsko, Norsko, Polsko, Portugalsko, Saúdská Arábie, Švýcarsko, USA, Velká Británie, Venezuela, ÿecko
Prostine VR	Francie
Vasaprostan	Rumunsko

Odkazy : Alprostadil

	typ	uveřejnění
1072	noviny	Saltsmann CL, Tom CM, Mitchell A, Fan JH, Gailey RA. Compatibility of levofloxacin with 34 medications during simulated Y-site administration. Am J Health-Syst Pharm 1999 ; 56: 1458-1459.
1899	noviny	Trissel LA, Zhang Y. Long-term stability of Trimix : a three drug injection used to treat rectile dysfunction. Int J Pharm Compound 2004 ; 8, 3: 231-235.
2003	noviny	Paul M, Razzouq N, Tixier G, Astier A. Stability of prostaglandin E1 (PGE1) in aqueous solutions. EJHP Science 2005 ; 2: 31-36.
2090	noviny	Pere H, Chasse V, Forest JM, Hildgen P. Compatibility of injectable pantoprazole in Y-site administration. Pharmactuel 2004 ; 37: 193-196.
2150	noviny	Soli M, Bertaccini A, carparelli F, Gotti R, Cavrini V, Andrisano V, Martorana G. Vasoactive cocktails for erectile dysfunction: chemical stability of PGE1, papaverine and phentolamine. J Urology 1998 ; 160; 2: 551-555.
2151	noviny	Gatti R, Gotti R, Cavrini V, Soli M, Bertaccini A, Carparelli F. Stability study of prostaglandin E1 (PGE1) in physiological solutions by liquid chromatography (HPLC). Int J Pharm 1995 ; 115: 113-117.
3201	noviny	Dice JE. Physical compatibility of alprostadil with commonly used IV solutions and medications in the neonatal intensive care unit. J Pediatr Pharmacol Ther 2006 ; 11:233?6.
3448	noviny	Vieillard V, Eychenne N, Astier A, Yiou R, Deffaux C, Paul M. Physicochemical stability study of a new Trimix formulation for treatment of erectile dysfunction. Ann Pharm Fr 2013 ; 71, 5: 358-363.
3761	kniha	Chavan E. Etude de la stabilité de solutions de prostaglandine E1 à 48 et 72 heures en vue d'une administration parentérale en continu à des patients de néonatalogie. Master en pharmacie - University of Geneva 2014
3961	noviny	McCluskey S.V,Kirkham K,Munson J.M. Stability of Alprostadil in 0.9% Sodium Chloride Stored in Polyvinyl Chloride Containers. Int J Pharm Compound 2017 ; 21, 2: 150-153.
4069	noviny	Palmero D, Chavan E, Berger-Gryllaki M, Tolsa J-F, Di Paolo E, Pannatier A, Henry H, Sadeghipour F. Stability of prostaglandin E1 solutions stored in polypropylene syringes for continuous intravenous administration to newborns. EJHP 2018 ; 25, e2
4389	noviny	Côté K, Correal F, Metras M.E, Friciu M, Forest J.M, Leclair G. Compatibilité physique des médicaments administrés en Y aux soins intensifs, en particulier la dexmédétomidine, le lévosimendan et la kétamine. Pharmactuel 2019 ;52,4:206-213
4491	noviny	De Basagoiti A, Katsumiti A, Abascal S, Bustinza A, López-Giménez L.R, Pilar P, De Miguel M, Campino A. Physical compatibility of alprostadil with selected drugs commonly used in the neonatal intensive care units. Eur J Pedia 2020
4507	noviny	Ross E, Salinas A, Petty K, Her C, Carpenter J. Compatibility of medications with intravenous lipid emulsions: Effects of simulated Y-site mixing. Am J Health-Syst Pharm 2020 ;77,23:1980-1985
4543	noviny	Senarathna G, Strunk T, Petrovski M, Batty K. Physical compatibility of pentoxifylline and intravenous medications. Archives of Disease in Childhood 2018 ;104:292–295.
4570	noviny	Greenhill K, Hornsby E, Gorman G. Investigations of Physical Compatibilities of Commonly Used Intravenous Medications with and without Parenteral Nutrition in Pediatric Cardiovascular Intensive Care Unit Patients. Pharmaceuticals 2019
4651	noviny	De Basagoiti A, Katsumiti A, Abascal S, Bustinza A, López-Giménez L.R, Pascual P, De Miguel M, Campino A. Physical compatibility of alprostadil with selected drugs commonly used in the neonatal intensive care units. Eur J Pedia 2021 ;180,1169–1176.
4837	noviny	De Silva, D.T.N Petrovski M, Strunk T, Mukadam N, Page‑Sharp N, Moore B.R, Batty K.T. Physicochemical compatibility of caffeine citrate and caffeine base injections with parenteral medications used in neonatal intensive care settings. Eur J Clin Pharmacol 2024 ; 80:1079–1087.

Mentions Légales